These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1902 related articles for article (PubMed ID: 7907615)
21. Morphometric, DNA and PCNA in thin malignant melanomas. Björnhagen V; Månsson-Brahme E; Lindholm J; Mattsson A; Auer G Med Oncol Tumor Pharmacother; 1993; 10(3):87-94. PubMed ID: 7903405 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. Jain S; Filipe MI; Hall PA; Waseem N; Lane DP; Levison DA J Clin Pathol; 1991 Aug; 44(8):655-9. PubMed ID: 1679766 [TBL] [Abstract][Full Text] [Related]
23. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients. Bianchi S; Paglierani M; Zampi G; Cardona G; Cataliotti L; Bonardi R; Zappa M; Ciatto S Cancer; 1993 Jul; 72(1):120-5. PubMed ID: 8099532 [TBL] [Abstract][Full Text] [Related]
25. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361 [TBL] [Abstract][Full Text] [Related]
26. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. Roels S; Tilmant K; Ducatelle R J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290 [TBL] [Abstract][Full Text] [Related]
27. Proliferating cell nuclear antigen/cyclin in incidental carcinoma of the prostate. Botticelli AR; Criscuolo M; Martinelli AM; Botticelli L; Filoni A; Migaldi M Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):365-8. PubMed ID: 7906910 [TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Mori M; Kakeji Y; Adachi Y; Moriguchi S; Maehara Y; Sugimachi K; Jessup JM; Chen LB; Steele GD Surgery; 1993 Jun; 113(6):683-90. PubMed ID: 8099452 [TBL] [Abstract][Full Text] [Related]
29. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267 [TBL] [Abstract][Full Text] [Related]
30. Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma. Skopelitou A; Korkolopoulou P; Papanikolaou A; Hadjiyannakis M J Cancer Res Clin Oncol; 1993; 119(7):379-81. PubMed ID: 8098331 [TBL] [Abstract][Full Text] [Related]
31. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815 [TBL] [Abstract][Full Text] [Related]
32. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Oda Y; Hashimoto H; Takeshita S; Tsuneyoshi M Cancer; 1993 Jul; 72(2):478-85. PubMed ID: 8100481 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer. Fujii M; Motoi M; Saeki H; Aoe K; Moriwaki S Acta Med Okayama; 1993 Apr; 47(2):103-8. PubMed ID: 8099466 [TBL] [Abstract][Full Text] [Related]
34. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections. Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513 [TBL] [Abstract][Full Text] [Related]
35. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis. Narita T; Funahashi H; Satoh Y; Takagi H Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256 [TBL] [Abstract][Full Text] [Related]
36. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas. Haerslev T; Jacobsen GK; Zedeler K Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578 [TBL] [Abstract][Full Text] [Related]
37. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288 [TBL] [Abstract][Full Text] [Related]
38. Lentigo maligna and superficial spreading melanoma are different in their in situ phase: an immunohistochemical study. Auslender S; Barzilai A; Goldberg I; Kopolovic J; Trau H Hum Pathol; 2002 Oct; 33(10):1001-5. PubMed ID: 12395373 [TBL] [Abstract][Full Text] [Related]
39. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate. Tu P; Miyauchi S; Miki Y Am J Dermatopathol; 1993 Aug; 15(4):311-4. PubMed ID: 8105711 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]